Evidence map›Paper›PMID 33517839›Full record

ArticleVirulence2021

Sox4 represses host innate immunity to facilitate pathogen infection by hijacking the TLR signaling networks.

Jian Shang, Yuan Zheng, Jiayin Mo, Wenbiao Wang, Zhen Luo, Yongkui Li, Xulin Chen, Qiwei Zhang, Kailang Wu, Weiyong Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Inhibitory Effects and Related Molecular Mechanisms of Huanglian-Ganjiang Combination Against H1N1 Influenza Virus.Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jian ShangGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.
Yuan ZhengState Key Laboratory of Virology, College of Life Sciences, Wuhan University , Wuhan, China.
Jiayin MoState Key Laboratory of Virology, College of Life Sciences, Wuhan University , Wuhan, China.
Wenbiao WangGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.
Zhen LuoGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.
Yongkui LiGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.
Xulin ChenGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.
Qiwei ZhangGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.
Kailang WuState Key Laboratory of Virology, College of Life Sciences, Wuhan University , Wuhan, China.
Weiyong LiuGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.
Jianguo WuGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University , Guangzhou, China.ORCID 0000-0002-8326-2895
Jinan University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptors (TLRs) are essential for the protection of the host from pathogen infections by initiating the integration of contextual cues to regulate inflammation and immunity. However, without tightly controlled immune responses, the host will be subjected to detrimental outcomes. Therefore, it is important to balance the positive and negative regulations of TLRs to eliminate pathogen infection, yet avert harmful immunological consequences. This study revealed a distinct mechanism underlying the regulation of the TLR network. The expression of sex-determining region Y-box 4 (Sox4) is induced by virus infection in viral infected patients and cultured cells, which subsequently represses the TLR signaling network to facilitate viral replication at multiple levels by a distinct mechanism. Briefly, Sox4 inhibits the production of myeloid differentiation primary response gene 88 (MyD88) and most of the TLRs by binding to their promoters to attenuate gene transcription. In addition, Sox4 blocks the activities of the TLR/MyD88/IRAK4/TAK1 and TLR/TRIF/TRAF3/TBK1 pathways by repressing their key components. Moreover, Sox4 represses the activation of the nuclear factor kappa-B (NF-κB) through interacting with IKKα/α, and attenuates NF-kB and IFN regulatory factors 3/7 (IRF3/7) abundances by promoting protein degradation. All these contributed to the down-regulation of interferons (IFNs) and IFN-stimulated gene (ISG) expression, leading to facilitate the viral replications. Therefore, we reveal a distinct mechanism by which viral pathogens evade host innate immunity and discover a key regulator in host defense.

Indexed as

Enterovirus A, HumanHep G2 CellsHumansImmunity, InnateInfluenza A virusLeukocytes, MononuclearMyeloid Differentiation Factor 88Signal TransductionSOXC Transcription FactorsToll-Like ReceptorsVirusesVirus ReplicationMyeloid Differentiation Factor 88SOX4 protein, humanSOXC Transcription FactorsToll-Like ReceptorsEnterovirus 71EV71HCVhepatitis C virusIAVIFNIFN regulatory factors 3/7IFN-stimulated geneinfluenza A virusinterferonIRF3/7ISGMyD88myeloid differentiation primary response gene 88sendai virusSEVsex-determining region Y-box 4Sox4TLRSToll-like receptorsvesicular stomatitis virusVSV

Identifiers

PMID33517839
PMCPMC7894441
OpenAlexW3127586740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.